Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a decentralized clinical trial technology company that entered the public markets through a SPAC merger with LifeSci Acquisition 2 Corp, a blank-check company sponsored by LifeSci Capital that completed its IPO in 2021. The company operates in the healthcare technology and clinical research sector, providing a technology platform and network designed to enable remote and decentralized clinical trials for biopharmaceutical sponsors and contract research organizations. The 10-Q filed on May 17, 2021, with accession number 0001104659-21-068146, reflects the company's early reporting period following the completion of the SPAC transaction. Visit SpacDesk and sign up for full filing data, timeline analytics, and sponsor intelligence on SNCE and hundreds of other SPAC transactions.